
About Testline Clinical Diagnostics
Testline Clinical Diagnostics is a Healthcare company based in Brno (Czechia) founded in 1993. Diagnostic assays for infectious diseases are developed and commercialized. Testline Clinical Diagnostics offers products and services including Control Set CLIA HSV 1+2 IgM, EIA RSV IgA, Microblot-Array HSV 1+2 IgM, and CLIA Tetanus Toxoid IgG. Its focus areas include Diversified Diagnostics. Its legal entity is TestLine Clinical Diagnostics s.r.o.
Company details
Testline Clinical Diagnostics was established in 1993 in Brno, Czech Republic, within the clinical diagnostics sector. Assays are developed and commercialized, encompassing ELISA, immunoblot, and smart EIA kits targeted at infectious diseases and immunology. Antibodies, antigens, and various consumables are distributed, with veterinary immunodiagnostics included in the portfolio. Operations focus on supporting laboratory and research applications in these fields.
- Headquarters Brno, Czechia
- SectorsHealthcare
- Website testlinecd.com
- Social LinkedIn YouTube
- Legal Name Testline Clinical Diagnostics S.R.O.
- Latest Funding Round$296.82K (USD), Grant
May 2021
- Investors
Products & Services of Testline Clinical Diagnostics
Testline Clinical Diagnostics offers a comprehensive portfolio of products and services, including Control Set CLIA HSV 1+2 IgM, EIA RSV IgA, Microblot-Array HSV 1+2 IgM, and CLIA Tetanus Toxoid IgG.
Control set for detecting HSV IgM via CLIA method
EIA kit for RSV IgA antibody detection in samples
Array for HSV 1+2 IgM testing in diagnostics
CLIA kit for measuring Tetanus Toxoid IgG levels
Apps and channels of Testline Clinical Diagnostics
its YouTube channel TestLine Clinical Diagnostics s.r.o. has 85 subscribers and 27 videos.
Videos from Testline Clinical Diagnostics
The most watched videos on Testline Clinical Diagnostics's YouTube channel, TestLine Clinical Diagnostics s.r.o. (85 subscribers). Click a video to play it here.
More on TestLine Clinical Diagnostics s.r.o..
Funding Insights of Testline Clinical Diagnostics
- Total Rounds 1
- Last Round Grant — $296,825
- First Round $296,825
(May 2021)
- Investors Count 1
All 1 funding rounds of Testline Clinical Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $296,825 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Testline Clinical Diagnostics
Testline Clinical Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Portál veřejné správy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A digital platform for public administration services in Czech Republic. | gov.cz | Czech Republic |
Investor details for Testline Clinical Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Testline Clinical Diagnostics
2 dated milestones of Testline Clinical Diagnostics across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Testline Clinical Diagnostics is founded.
- Funding First funding round of $297K.
Web traffic of Testline Clinical Diagnostics
The website of Testline Clinical Diagnostics (testlinecd.com) receives about 1.3K visits a month.
- Monthly visits1.3K
Websites whose visitors overlap most with Testline Clinical Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vircell.com | 100% | #787,345 | View details | ||
euroimmun.pl | euroimmun.pl | 65% | #2,240,929 | – | |
| testline.in | 24% | 7.9K | #2,459,738 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Testline Clinical Diagnostics
Testline Clinical Diagnostics was founded in 1993 and raised its 1st funding round 28 years after it was founded.
Testline Clinical Diagnostics is headquartered in Brno, Czechia. It is registered at Brno, South Moravian Region, Czechia.
Testline Clinical Diagnostics was established in 1993 in Brno, Czech Republic, within the clinical diagnostics sector. Assays are developed and commercialized, encompassing ELISA, immunoblot, and smart EIA kits targeted at infectious diseases and immunology. Antibodies, antigens, and various consumables are distributed, with veterinary immunodiagnostics included in the portfolio. Operations focus on supporting laboratory and research applications in these fields.
Testline Clinical Diagnostics offers Control Set CLIA HSV 1+2 IgM, EIA RSV IgA, Microblot-Array HSV 1+2 IgM, and CLIA Tetanus Toxoid IgG.
Testline Clinical Diagnostics has 1 investor. Key investors include Portál veřejné správy.
Testline Clinical Diagnostics operates through Testline Clinical Diagnostics S.R.O..